In this article you get to know insight about Blue Jet Healthcare Limited IPO Details. Blue Jet Healthcare is a pharmaceutical and healthcare ingredient and intermediate company with a rich history dating back to its incorporation in 1968. It holds a prominent position in the pharmaceutical industry and is known for its pioneering role in India as the first manufacturer of saccharin and its salts, which are artificial sweeteners. Over the years, the company has diversified its product portfolio to include contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients. Blue Jet Healthcare is a global pharmaceutical firm driven by scientific innovation.
Process Development and Production Capabilities: Blue Jet Healthcare has established strong capabilities in developing pharmaceutical processes and production. This enables them to produce a variety of pharmaceutical products efficiently.
Global Regulatory Support: The company provides regulatory support on a global scale, ensuring compliance with pharmaceutical regulations and standards worldwide.
Collaboration, Development, and Manufacturing: Blue Jet Healthcare collaborates with partners for the development and manufacturing of advanced pharmaceutical intermediates and active pharmaceutical ingredients (API).
The company’s operations are supported by three manufacturing facilities located in Shahad (Unit I), Ambernath (Unit II), and Mahad (Unit III) within the state of Maharashtra, India. As of June 30, 2023, these facilities have annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively.
Key strengths of Blue Jet Healthcare include:
Huge Manufacturing Capacity: The company boasts a significant manufacturing capacity, particularly in the production of contrast media intermediates within India. This capacity enables them to meet the demands of the market effectively.
Niche Market Presence: Blue Jet Healthcare operates in a niche market characterized by high entry barriers. This positioning allows the company to serve specialized needs and maintain a competitive advantage.
Long-Term Relationships: The company has established enduring relationships and long-term contracts with multinational customers. This not only reflects their commitment to customer satisfaction but also provides a stable and predictable revenue stream.
Blue Jet Healthcare’s legacy, manufacturing capabilities, and specialization in key pharmaceutical segments position it as a notable player in the pharmaceutical and healthcare industry.
Objects of the Issue
It’s important to note that the company itself will not receive any proceeds from the Offer. Instead, all the Offer Proceeds will be received by the Selling Shareholders. The distribution of these proceeds among the Selling Shareholders will be in proportion to the Offered Shares sold by each respective Selling Shareholder as part of the Offer. This arrangement ensures that the funds raised through the Offer go directly to the individuals or entities selling their shares, reflecting the nature of the transaction.
Blue Jet Healthcare Limited IPO Details
| IPO Date | October 25, 2023 to October 27, 2023 |
| Face Value | ₹2 per share |
| Price | ₹329 to ₹346 per share |
| Lot Size | 43 Shares |
| Total Issue Size | 24,285,160 shares (aggregating up to ₹840.27 Cr) |
| Fresh Issue | |
| Issue Type | Book Built Issue IPO |
| Listing | BSE, NSE |
| Share holding pre issue | 173,465,425 |
| Share holding post issue | 173,465,425 |
| Market Maker portion |
Blue Jet Healthcare Limited IPO Reservation
QIB (Qualified Institutional Buyers) Shares Offered: Not more than 50% of the Net Issue will be allocated to QIBs. These are institutional investors who meet specific criteria and are considered well-versed in financial markets.
Retail Shares Offered: At least 35% of the Net Issue is reserved for retail investors. Retail investors are typically individual investors who purchase shares for personal investment purposes.
NII (Non-Institutional Investors, HNI) Shares Offered: At least 15% of the Net Issue is allocated to Non-Institutional Investors (NII), including High Net Worth Individuals (HNI). These are investors who may not be institutions but have a substantial investment capacity.
This allocation strategy aims to ensure that a portion of the IPO shares is set aside for different categories of investors, including both institutions and individual investors, promoting inclusivity and allowing a diverse range of investors to participate in the offering based on their respective categories and investment goals.
Blue Jet Healthcare Limited IPO Tentative Dates
| IPO Open Date | Wednesday, October 25, 2023 |
| IPO Close Date | Friday, October 27, 2023 |
| Basis of Allotment | Wednesday, November 1, 2023 |
| Initiation of Refunds | Thursday, November 2, 2023 |
| Credit of Shares to Demat | Friday, November 3, 2023 |
| Listing Date | Monday, November 6, 2023 |
| Cut-off time for UPI mandate confirmation | 5 PM on October 27, 2023 |
Blue Jet Healthcare Limited IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: bluejet.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html
FAQs
What is Blue Jet Healthcare Limited, and what does it specialize in?
Blue Jet Healthcare Limited is a pharmaceutical and healthcare ingredient and intermediate company. It is known for its pioneering role in manufacturing saccharin and its salts, artificial sweeteners. The company has diversified its product portfolio to include contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients.
What are some key strengths of Blue Jet Healthcare Limited as a pharmaceutical company?
Blue Jet Healthcare boasts a significant manufacturing capacity, specializes in contrast media intermediates, operates in a niche market, and has established long-term relationships with multinational customers.
When is Blue Jet Healthcare Limited’s IPO scheduled to take place?
The Blue Jet Healthcare Limited IPO is scheduled to be open for subscription from October 25, 2023, to October 27, 2023.
What is the face value of Blue Jet Healthcare Limited’s shares?
The face value of Blue Jet Healthcare Limited shares is ₹2 per share.
How is the IPO issue structured in terms of share allocation?
The IPO is a Book Built Issue IPO, and the shares will be listed on BSE and NSE. A total of 173,465,425 shares are being offered.
Who will receive the proceeds from the IPO, and how will it be distributed?
The company itself will not receive any proceeds from the IPO. All the proceeds from the Offer will go to the Selling Shareholders in proportion to the Offered Shares sold by each respective Selling Shareholder.
What is the reservation allocation for various categories of investors in the Blue Jet Healthcare Limited IPO?
The allocation includes:
QIB (Qualified Institutional Buyers) – Not more than 50% of the Net Issue.
Retail Investors – At least 35% of the Net Issue.
NII (Non-Institutional Investors, HNI) – At least 15% of the Net Issue.
What are the tentative dates for the Blue Jet Healthcare Limited IPO process?
The IPO opens on Wednesday, October 25, 2023, and closes on Friday, October 27, 2023. The listing date is Monday, November 6, 2023.
Who is the registrar for the Blue Jet Healthcare Limited IPO, and how can investors contact them?
The registrar for the IPO is Link Intime India Private Ltd. Investors can contact them at +91-22-4918 6270 or via email at bluejet.ipo@linkintime.co.in.